Weidong Liu

This inventor holds 15 USPTO granted patents, plus 3 CIPO patents and 5 EPO patents. Top assignees: Array Biopharma Inc., Novartis Ag, Loxo Oncology, Inc.. Active years: 2010-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weidong Liu. Retrieved from https://idiyas.com/inventor/weidong-liu-hbfo5sff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 86.7

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 9.5

ph-index = 5

Forward Citations = 109(Granted Patents)

Location History:

Superior, CO (US) (2010 - 2020)
Boulder, CO (US) (2016 - 2020)
Longmont, CO (US) (2020 - 2023)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2010-2023

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11807651 - Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile (2023-11-07),

2. 11098064 - Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile (2021-08-24),

3. 10835533 - 1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor (2020-11-17),

4. 10745419 - Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile (2020-08-18),

5. 10729678 - Preparation of and formulation comprising a MEK inhibitor (2020-08-04),

6. 10398683 - Preparation of and formulation comprising a MEK inhibitor (2019-09-03),

7. 10329288 - Process for preparing a compound (2019-06-25),

8. 9980944 - Preparation of and formulation comprising a MEK inhibitor (2018-05-29),

9. 9598376 - Preparation of and formulation comprising a MEK inhibitor (2017-03-21),

10. 9562016 - Preparation of and formulation comprising a MEK inhibitor (2017-02-07),

11. 9382212 - Preparation of and formulation comprising a MEK inhibitor (2016-07-05),

12. 9238627 - Preparation of and formulation comprising a MEK inhibitor (2016-01-19),

13. 8648087 - N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases (2014-02-11),

14. 8299021 - Macrocyclic inhibitors of hepatitis C virus replication (2012-10-30),

15. 7829665 - Macrocyclic inhibitors of hepatitis C virus replication (2010-11-09),

Title: The Innovative Journey of Inventor Weidong Liu

Introduction: Weidong Liu, a talented inventor based in Boulder, CO, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Weidong Liu holds several patents in the areas of artificial intelligence, renewable energy, and advanced materials, showcasing his diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Weidong Liu has successfully brought several cutting-edge inventions to life, revolutionizing industries along the way.

Collaborations: Throughout his career, Weidong Liu has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions, solidifying his reputation as a visionary inventor.

Conclusion: Weidong Liu's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.